News and Events

FyoniBio collaborates with BioLamina and Alder Therapeutics

FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications.

FyoniBio gets CIR accreditation

We are pleased to announce that FyoniBio has received CIR (Crédit d’Impôt Recherche or CIR) accreditation for three years until 2025, which will benefit our French clientele.

Launch of FyoniBio’s CHOFlow® Technology

CHOFlow®: Our high yield expression technology for afucosylated ADCC enhanced antibodies and beyond.

Successful Cell Line Development for Strike Pharma

Strike Pharma and FyoniBio Conclude Successfully Cell Line Development of Strike’s Bi-specific Antibody and Clinical Lead Candidate.

Service Agreement with adivo

FyoniBio and adivo GmbH sign a Service Agreement covering the generation of a production cell line for their canine therapeutic mAb candidate

Cooperation with Strike Pharma

We have signed a Master Service Agreement with Strike Pharma covering the cell line development for a novel bi-specific therapeutic mAb.

Partnership with ProteoNic

We have signed a license agreement for using ProteoNic’s 2G Unic™ technology in our cell line development platform.

Launch of FyoniBio GmbH

The FyoniBio service branch of Glycotope GmbH will continue its business as FyoniBio GmbH.

Cooperation with BioGenes

BioGenes and FyoniBio begin a cooperation for Pharmacokinetic & Immunogenicity Analyses

Collaboration with CSL Behring

We are happy to have initiated a collaboration with CSL Behring research division.

BioProcess International Europe 2025

FyoniBio is looking forward to being a part of Bioprocess International Europe- the leading bioprocessing event for mAbs, novel modalities and biologics. The event held in Hamburg, brings together top scientists and suppliers working in biopharmaceutical development and manufacturing.

12-15 May 2025

PEGS Boston 2025

As the industry converges in Boston, FyoniBio is proud to join the conversation, driving the future of biologics and protein engineering. A leading event for biologics and protein engineering, it gathers a global community of experts, innovators, and leaders in the field.

12-16 May 2025

BIO International Convention US

We’re gearing up for BIO International Convention US 2025—the premier global event uniting biotech leaders, innovators, and visionaries. This dynamic gathering promises cutting-edge insights into breakthrough therapies and transformative technologies.

16-19 June 2025